ClinicalTrials.Veeva

Menu

Clinical Outcomes of Patients With COVID19

G

Guangzhou Institute of Respiratory Disease

Status

Withdrawn

Conditions

Coronavirus Disease 2019

Treatments

Other: retrospective analysis

Study type

Observational

Funder types

Other

Identifiers

NCT04280913
GZHZ-COVID19

Details and patient eligibility

About

As of February 17th, 2020, China has 70635 confirmed cases of coronavirus disease 2019 (COVID-19), including 1772 deaths. Human-to-human spread of virus via respiratory droplets is currently considered to be the main route of transmission. The number of patients increased rapidly but the impact factors of clinical outcomes among hospitalized patients are still unclear.

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Hospitalized patients with COVID19

Exclusion criteria

  • Suspected patients with COVID19, not confirmed by the laboratory
  • Patients who are refused to receive medical treatments

Trial design

0 participants in 1 patient group

COVID-19 patients
Description:
Hospitalized patients with COVID-19
Treatment:
Other: retrospective analysis

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems